2025 second_quarter Filing

Discussions concerning the FY 2024 appropriations bills; provisions related to FDA regulation of tobacco.

Discussions concerning federal funding related to the Centers for Disease Control and Prevention.

Discussions related to implementation of P.L. 111-31 Family Smoking Prevention and Tobacco Control Act. Discussions related to tobacco harm reduction. Discussions related to enforcement of illicit tobacco products, including importation of counterfeit products. Discussions related to user fees for tobacco and electronic nicotine delivery system products. Discussions related to efforts to prevent youth access to tobacco products.